Dako, an Agilent Technologies (NYSE: A) company and a worldwide provider of cancer diagnostics, announced the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE